Innovative Drug R&D on the Rise in China: Technically Savvy Returnees, Influx of VC Funding, and Solid Gov't Support Buoy Efforts

摘要

As the Chinese pharmaceutical industry expands rapidly, Chinese pharma and biotech companies— and even outsourcing service providers—are increasingly paying attention to and investing in innovative drug R&D. A flotilla of returnees and venture capital firms are aiding in these endeavors.